Collegium Pharmaceutical (COLL) Shares Outstanding (2014 - 2026)

Collegium Pharmaceutical has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $32.5 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.01% year-over-year to $32.5 million in Q2 2026; TTM through Jun 2026 was $32.5 million, a 3.01% increase from a year earlier, with the FY2025 full-year figure at $31.7 million, up 0.85% from the prior year.
• Shares Outstanding (Entity) was $32.5 million for Q2 2026 at Collegium Pharmaceutical, roughly flat from $32.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $34.7 million in Q2 2023, with the low at $31.4 million in Q4 2024.
• Average Shares Outstanding (Entity) over 5 years is $32.8 million, with a median of $32.5 million recorded in 2026.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) fell 6.91% in 2024, then increased 3.01% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $33.8 million in 2022, then declined by 5.85% to $31.9 million in 2023, then retreated by 1.34% to $31.4 million in 2024, then advanced by 0.85% to $31.7 million in 2025, then grew by 2.49% to $32.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $32.5 million (Q2 2026), $32.4 million (Q1 2026), and $31.7 million (Q4 2025), per Business Quant data.